Published in Clinical Oncology Week, August 9th, 2010
"Patients were classified as either favorable or unfavorable by a 144-gene prediction analysis for microarrays (PAM) classifier established...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.